Zobrazeno 1 - 10
of 414
pro vyhledávání: '"M Lémann"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Lémann
Publikováno v:
Alimentary Pharmacology and Therapeutics. 24:22-28
Summary The decision regarding prophylactic treatment after surgery in Crohn's disease (CD) requires a good estimation of the risk of recurrence. It is also important to consider the consequences of recurrence for the patient, and the risks and benef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caa15dc93f3d8a3d10639c7230ccf0b4
https://doi.org/10.1111/j.1365-2036.2006.03055.x
https://doi.org/10.1111/j.1365-2036.2006.03055.x
Autor:
M Lémann, G Naudin, A Attar, E Alix, S Chaussade, B Flourié, M Salmeron, M Barthet, J Moreau, M Halphen, F Guillemot, M C Boutron, Anne Ferguson, A M Ménard
Publikováno v:
Gut. 44:226-230
BackgroundPolyethylene glycol (PEG) 3350 is a non-absorbable, non-metabolised osmotic agent used in lavage solutions for gut cleansing.AimsTo compare the efficacy of PEG and lactulose in chronic constipation.MethodsA total of 115 patients with chroni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcf5a773b247ee58630b8dffee3a6de7
https://doi.org/10.1136/gut.44.2.226
https://doi.org/10.1136/gut.44.2.226
Autor:
M. Lémann
Publikováno v:
Gastroentérologie Clinique et Biologique. 32:486-488
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80fba018a519a0b24a66c1068de2fea8
https://doi.org/10.1016/j.gcb.2008.03.006
https://doi.org/10.1016/j.gcb.2008.03.006
Autor:
V. CANVA-DELCAMBRE, S. JACQUOT, E. ROBINET, M. LÉMANN, C. DROUET, M. LABALETTE, J.-P. DESSAINT, D. ENGOUFA, B C. RABIAN, R. MODIGLIANI, J. WIJDENES, J.-P. REVILLARD, J.-F. COLOMBEL
Publikováno v:
Alimentary Pharmacology & Therapeutics. 10:721-727
Background: Monoclonal CD4 antibodies have been proposed as a new immunosuppressant drug in the treatment of inflammatory bowel disease. We report our experience of treatment with a monoclonal anti-CD4 (B-F5) antibody in severe refractory Crohn's dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c02e50bb7306a71fc3b5e54c768bc6fb
https://doi.org/10.1046/j.1365-2036.1996.59201000.x
https://doi.org/10.1046/j.1365-2036.1996.59201000.x
Publikováno v:
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 23(5)
In healthy humans, up to 30 g of daily ingested starch escape small intestinal digestion, and are fermented in the colon. This physiological starch malabsorption could modify colonic motility through metabolites such as short-chain fatty acids produc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::66f989c5531c4a98ebf94f10a4a326b2
https://pubmed.ncbi.nlm.nih.gov/21199172
https://pubmed.ncbi.nlm.nih.gov/21199172
Publikováno v:
Annales de dermatologie et de venereologie. 134(8-9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1eb2bb4e53c4a2563fa08ad82cfe6def
https://pubmed.ncbi.nlm.nih.gov/17925707
https://pubmed.ncbi.nlm.nih.gov/17925707
Autor:
B, De Singly, M, Simon, J, Bennani, S, Wittnebel, A-M, Zagadanski, V, Pacault, J-M, Gornet, M, Allez, M, Lémann
Publikováno v:
Gastroenterologie clinique et biologique. 32(4)
Acute pancreatitis is not infrequent after allogenic marrow transplantation. Several causes can predispose to pancreatitis, including Graft-Versus-Host Disease (GVHD), a condition which is probably underestimated. In the literature, few description o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::50eb0c4766281882f89291898ad9e20d
https://pubmed.ncbi.nlm.nih.gov/18378104
https://pubmed.ncbi.nlm.nih.gov/18378104
Autor:
B, Bonaz, J, Boitard, P, Marteau, M, Lémann, B, Coffin, B, Flourié, J, Belaiche, G, Cadiot, E-H, Metman, A, Cortot, J-F, Colombel
Publikováno v:
Alimentary pharmacologytherapeutics. 18(4)
Tioguanine (TG) is an antimetabolite which may be regarded as an alternative to azathioprine (AZA)/mercaptopurine (MP) in patients with inflammatory bowel diseases.: To evaluate the tolerance and efficacy of TG in patients with Crohn's disease, intol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5ef5d3178e5cb187fd3592ba86ff72c4
https://pubmed.ncbi.nlm.nih.gov/12940925
https://pubmed.ncbi.nlm.nih.gov/12940925
Publikováno v:
Value in Health. 14:A548-A549
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cd82a62963eaf0acdf623724ff8d533
https://doi.org/10.1016/j.jval.2011.08.1598
https://doi.org/10.1016/j.jval.2011.08.1598